Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-4-4
pubmed:abstractText
Interleukin-1 receptor antagonist (IL-1Ra) is involved in many processes, including epidermal inflammation and hyperplasia after irritation or injury. However, the mechanism by which intracellular IL-1Ra (icIL-1Ra) expression is regulated in mouse keratinocytes has not been reported. We found that the CH72 mouse carcinoma cell line constitutively expresses the icIL-1Ra mRNA. To study the transcriptional factors responsible for the constitutive expression of icIL-1Ra, we functionally characterized 4.5 kb of the 5' flanking region of the human icIL-1Ra gene in these cells. We first demonstrated that icIL-1Ra expression in these cells was regulated at the level of transcription. Deletion analysis of the promoter showed that regulatory elements for constitutive expression were located -158 to -49 bp upstream of the transcription start site for icIL-1Ra. We investigated the cis- and trans-acting factors required for icIL-1Ra expression. An activating protein-1 (AP-1) site was identified as the positive regulatory element necessary for the constitutive expression of the icIL-1Ra promoter in CH72 cells. Moreover, electrophoretic mobility shift assay and cotransfection experiments showed that c-jun and c-fos proteins bound to the AP-1 site and functionally transactivated the icIL-1Ra promoter in mouse carcinoma CH72 cells.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0899-1987
pubmed:author
pubmed:copyrightInfo
Copyright 2002 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
237-43
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11933077-Animals, pubmed-meshheading:11933077-Base Sequence, pubmed-meshheading:11933077-Carcinoma, Squamous Cell, pubmed-meshheading:11933077-Consensus Sequence, pubmed-meshheading:11933077-Gene Expression Regulation, Neoplastic, pubmed-meshheading:11933077-Genes, Reporter, pubmed-meshheading:11933077-Interleukin 1 Receptor Antagonist Protein, pubmed-meshheading:11933077-Luciferases, pubmed-meshheading:11933077-Mice, pubmed-meshheading:11933077-Recombinant Proteins, pubmed-meshheading:11933077-Sequence Alignment, pubmed-meshheading:11933077-Sequence Deletion, pubmed-meshheading:11933077-Sialoglycoproteins, pubmed-meshheading:11933077-Skin Neoplasms, pubmed-meshheading:11933077-Transcription, Genetic, pubmed-meshheading:11933077-Transcription Factor AP-1, pubmed-meshheading:11933077-Transfection, pubmed-meshheading:11933077-Tumor Cells, Cultured
pubmed:year
2002
pubmed:articleTitle
Regulation of transcription of the intracellular interleukin-1 receptor antagonist gene by AP-1 in mouse carcinoma cells.
pubmed:affiliation
The University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.